THE EFFECT OF HEPTAKIS (2,6-DI-O-METHYL)-GAMMA-CYCLODEXTRIN ON MITOMYCIN-C STABILITY IN AQUEOUS-SOLUTION

被引:2
|
作者
SUENAGA, A
BEKERS, O
BEIJNEN, JH
UNDERBERG, WJM
TANIMOTO, T
KOIZUMI, K
OTAGIRI, M
机构
[1] KUMAMOTO UNIV,FAC PHARMACEUT SCI,DEPT PHARMACEUT,5-1 OE HONMACHI,KUMAMOTO 862,JAPAN
[2] STATE UNIV UTRECHT,FAC PHARM,DEPT PHARMACEUT ANAL,3511 GH UTRECHT,NETHERLANDS
[3] SLOTERVAART HOSP,NETHERLANDS CANC INST,1066 EC AMSTERDAM,NETHERLANDS
[4] MUKOGAWA WOMENS UNIV,FAC PHARMACEUT SCI,NISHINOMIYA,HYOGO 663,JAPAN
关键词
Heptakis (2,3,6-tri-O-methyl)-γ-cyclodextrin; Heptakis (2,6-di-O-methyl)-γ-cyclodextrin; Inclusion complex; Mitomycin C degradation; Stabilization; γ-Cyclodextrin;
D O I
10.1016/0378-5173(90)90086-J
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The inclusion of mitomycin C in γ-cyclodextrin and two of its methylated derivatives has been investigated as well as the effect of the process on the stability of the guest molecule. Inclusion of mitomycin C in heptakis (2,6-di-O-methyl)-γ-cyclodextrin has the greatest effect, whilst in γ-cyclodextrin it is less pronounced and in the case of heptakis (2,3,6-tri-O-methyl)-γ-cyclodextrin activity was undetectable. On complexation with cyclodextrins, the degradation of mitomycin C proceeds at a slower rate, in both acidic and alkaline media. The effect of heptakis (2,6-di-O-metnyl)-γ-cyclodextrin is also greater in this respect and is apparently correlated with the stability of the complex. Using CD and H NMR spectroscopy some insight has been gained into the structure of mitomycin C-cyclodextrin complexes. © 1990.
引用
收藏
页码:121 / 130
页数:10
相关论文
共 50 条
  • [1] STABILIZATION OF DAUNORUBICIN AND 4-DEMETHOXYDAUNORUBICIN ON COMPLEXATION WITH OCTAKIS(2,6-DI-O-METHYL)-GAMMA-CYCLODEXTRIN IN ACIDIC AQUEOUS-SOLUTION
    SUENAGA, A
    BEKERS, O
    BEIJNEN, JH
    UNDERBERG, WJM
    TANIMOTO, T
    KOIZUMI, K
    OTAGIRI, M
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 82 (1-2) : 29 - 37
  • [2] Calorimetric and spectroscopic characterization of complexes between β-cyclodextrin or heptakis (2,6-di-O-methyl)-β-cyclodextrin and sertraline hydrochloride in aqueous solution
    Belica, S.
    Jeziorska, D.
    Urbaniak, P.
    Buko, V. U.
    Zavodnik, I. B.
    Palecz, B.
    JOURNAL OF CHEMICAL THERMODYNAMICS, 2014, 70 : 160 - 167
  • [3] Inclusion phenomena of clove oil with α-, β-, γ- and heptakis (2,6-di-O-methyl)-β-cyclodextrin
    Song, L. X.
    Xu, P.
    Wang, H. M.
    Yang, Y.
    NATURAL PRODUCT RESEARCH, 2009, 23 (09) : 789 - 800
  • [4] HEPTAKIS(2,6-DI-O-METHYL)-BETA-CYCLODEXTRIN COMPLEXATION, WITH GLUTETHIMIDE
    ELGENDY, GA
    ELGENDY, MA
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1993, 39 (06) : 249 - 254
  • [5] STABILIZATION OF AN ANTHRAPYRAZOLE ANTITUMOR AGENT, DUP-937, ON COMPLEXATION WITH HEPTAKIS(2,6-DI-O-METHYL)-BETA-CYCLODEXTRIN IN AQUEOUS-SOLUTION
    RAGHAVAN, K
    NEMETH, G
    GRAY, D
    HUSSAIN, MA
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1994, 12 (10) : 1259 - 1264
  • [6] Encapsulation of 6-hydroxyquinoline in heptakis(2,6-di-O-methyl)-β-cyclodextrin
    Lee, Young-Shin
    Park, Han Jung
    Jang, Du-Jeon
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2006, 27 (09) : 1450 - 1452
  • [7] The Heptakis-(2,6-di-O-methyl)-β-cyclodextrin inclusion complex with acetic acid
    ER5128-CNRS, Centre Pharmaceutique, Université Paris-Sud, 92296 Chátenay-Malabry, France
    不详
    J. Incl. Phenom., 1 (1-12):
  • [8] The Heptakis-(2,6-di-O-methyl)-β-cyclodextrin Inclusion Complex with Acetic Acid
    M. Selkti
    A. Navaza
    F. Villain
    P. Charpin
    C. De Rango
    Journal of inclusion phenomena and molecular recognition in chemistry, 1997, 27 : 1 - 12
  • [9] COMPLEX-FORMATION OF HEXAKIS(2,6-DI-O-METHYL)-ALPHA-CYCLODEXTRIN WITH SUBSTITUTED BENZENES IN AQUEOUS-SOLUTION
    HARATA, K
    JOURNAL OF INCLUSION PHENOMENA AND MOLECULAR RECOGNITION IN CHEMISTRY, 1992, 13 (01): : 77 - 86
  • [10] Formation, characterization and pH dependence of rifampicin: heptakis( 2,6-di-O-methyl)-β-cyclodextrin complexes
    Angiolini, Lorenzo
    Agnes, Marco
    Cohen, Boiko
    Yannakopoulou, Konstantina
    Douhal, Abderrazzak
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 531 (02) : 668 - 675